[HTML][HTML] Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - Elsevier
… prospective trial comparing gefitinib and erlotinib treatment. In this study, we retrospectively
… The aim of the study was to identify clinical predictors to assist physicians in selecting …
… The aim of the study was to identify clinical predictors to assist physicians in selecting …
Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe… - Medical oncology, 2013 - Springer
… study has several limitations as of the nature of retrospective design; our data suggest that
gefitinib and erlotinib … , although erlotinib appears to have higher toxicity than gefitinib at each …
gefitinib and erlotinib … , although erlotinib appears to have higher toxicity than gefitinib at each …
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
Y Jiang, J Zhang, J Huang, B Xu, N Li, L Cao… - BMC Pulmonary …, 2018 - Springer
… The purpose of this study was to compare clinical outcomes of Erlotinib versus Gefitinib in
the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly …
the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly …
… predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric study
P Cioffi, V Marotta, C Fanizza… - Journal of Oncology …, 2013 - journals.sagepub.com
… In this retrospective, observational, multicentric study, we assessed effectiveness and
potentially response predictive factors in 222 unselected Italian patients, with stage IIIB/IV non-…
potentially response predictive factors in 222 unselected Italian patients, with stage IIIB/IV non-…
Retrospective study of erlotinib in patients with advanced squamous lung cancer
JS Tseng, TY Yang, KC Chen, KH Hsu, HY Chen… - Lung Cancer, 2012 - Elsevier
… this study was to evaluate the status of erlotinib … studies that have reported the ORR of
erlotinib in East Asian lung SCC patients. Studies that focused on efficacy of erlotinib after gefitinib …
erlotinib in East Asian lung SCC patients. Studies that focused on efficacy of erlotinib after gefitinib …
[PDF][PDF] Retrospective analysis of gefitinib and erlotinib in EGFR-mutated non-small-cell lung cancer patients
C Pui, C Gregory, Z Lunqing, LI Long… - Journal of Lung …, 2017 - lungdiseasesjournal.com
… In order to further evaluate the effectiveness between gefitinib and erlotinib, this study also …
PFS in erlotinib group (p=0.0162). This superiority of performance in erlotinib treatment group …
PFS in erlotinib group (p=0.0162). This superiority of performance in erlotinib treatment group …
[HTML][HTML] The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non …
HA Jung, SY Woo, SH Lee, JS Ahn… - … Cancer Research, 2020 - ncbi.nlm.nih.gov
… Afatinib had a superior tendency in terms of CNS-PFS, and cumulative incidence of CNS
failure compared with gefitinib or erlotinib. However, our study, as a retrospective study, has …
failure compared with gefitinib or erlotinib. However, our study, as a retrospective study, has …
… with non-small cell lung cancer harboring minor epidermal growth factor receptor mutations: results from a multicenter retrospective study (HANSHIN Oncology Group …
T Otsuka, M Mori, Y Yano, J Uchida… - … Research, 2015 - ar.iiarjournals.org
… of the EGFR gene who received either gefitinib or erlotinib between July 2002 and March
2012 at institutions participating in the Hanshin Cancer Research Group were included. The cut…
2012 at institutions participating in the Hanshin Cancer Research Group were included. The cut…
Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell …
N Aiko, T Shimokawa, K Miyazaki, Y Misumi, Y Agemi… - BMC cancer, 2018 - Springer
… study was to evaluate retrospectively the effect of two first-generation EGFR-TKIs (gefitinib
and erlotinib… more frequently in erlotinib group than gefitinib group in our study. Lee CK et al. …
and erlotinib… more frequently in erlotinib group than gefitinib group in our study. Lee CK et al. …
Efficacy and Safety of Gefitinib Plus Anlotinib for Patients with EGFR Positive Advanced Non-Small-Cell Lung Cancer: A Retrospective Exploratory Study
WX Hu, JC Peng, Y Wang, H Jin… - International Journal of …, 2022 - Taylor & Francis
… included in this study retrospectively. All patients were administered with gefitinib plus anlotinib
… Citation14 Therefore, we noticed that bevacizumab plus erlotinib combination therapy …
… Citation14 Therefore, we noticed that bevacizumab plus erlotinib combination therapy …
相关搜索
- different efficacies retrospective multicenter study
- asian patients retrospective multicenter study
- study of erlotinib gefitinib treatment
- effect of gefitinib retrospective cohort study
- afatinib erlotinib and gefitinib
- observational multicentric study
- phase ii trial of erlotinib
- study of erlotinib lung cancer
- retrospective analysis gefitinib and erlotinib
- efficacy of erlotinib trust study
- retrospective exploratory study safety of gefitinib
- taiwanese patients retrospective multicenter study
- brain metastases retrospective multicenter study
- lung adenocarcinoma retrospective multicenter study
- cell lung cancer retrospective multicenter study
- multicentric study response predictive factors